Search Results - "Sandalic, L."

561P Phase Ib study of ribociclib (R) + trametinib (T) in patients (pts) with metastatic/advanced solid tumours by LoRusso, P., Fakih, M., De Vos, F.Y.F.L., Beck, J.T., Merchan, J., Shapiro, G., Lin, C-C., Desai, J., Spratlin, J., Cascella, T., Sandalic, L., Abdelhady, A.M., Boran, A., Gasal, E., Janku, F., Van Cutsem, E.

Get full text

Randomized, phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemia by Sekeres, Mikkael A, Lancet, Jeffrey E, Wood, Brent L, Grove, Laurie E, Sandalic, Larissa, Sievers, Eric L, Jurcic, Joseph G

“…Improving outcomes in older adults with acute myeloid leukemia remains a formidable challenge. Lintuzumab (SGN-33; HuM195) is a humanized monoclonal antibody…”
Get full text

Serum-free estradiol (E2) levels are prognostic in men with chemotherapy-naive advanced non-small cell lung cancer (NSCLC) and performance status (PS) 2 by Ross, H., Oldham, F. B., Bandstra, B., Sandalic, L., Bianco, J., Bonomi, P., Singer, J. W.

“…Abstract only 7683 Background: In women with advanced NSCLC, premenopausal estradiol levels are associated with a worse survival than postmenopausal levels,…”
Get full text

Serum cathepsin B (CB) levels are prognostic in chemotherapy-naive patients (pts) with advanced non-small cell lung cancer (NSCLC) and performance status (PS) of 2 by Singer, J. W., Oldham, F. B., Bandstra, B., Sandalic, L., Bianco, J., Bonomi, P., Ross, H.

“…Abstract only 18036 Background: CB is an estrogen-influenced lysosomal cysteine protease produced by tumor cells and tumor-associated macrophages; tumor tissue…”
Get full text